慢加急性肝衰竭的免疫治疗

炎症反应和免疫功能紊乱在慢加急性肝衰竭的病程进展中发挥关键作用,导致全身炎症反应综合征,过度的炎症及免疫反应,导致感染易感性增加,最终出现多脏器功能衰竭(MODS)。消除肝损伤并纠正免疫紊乱可预防败血症和(或)MODS,改善患者的生存。迄今为止,ACLF的免疫治疗在各大治疗指南中尚未被推荐。然而,作为ACLF重要病理生理改变,并且与发病率、病死率密切相关的关键事件——肝脏局部和全身炎症反应持续激活及免疫细胞功能障碍,又促使我们不得不考虑免疫调节治疗,以阻断和逆转疾病的进展。因此,简述了目前应用于ACLF治疗的具有潜在免疫调节作用的药物,包括传统药物白蛋白、糖皮质激素等使用,粒细胞集落刺激因子、...

Full description

Saved in:
Bibliographic Details
Published in临床肝胆病杂志 Vol. 33; no. 9; pp. 1677 - 1682
Main Author 韩英 崔丽娜 郭冠亚
Format Journal Article
LanguageChinese
Published 第四军医大学西京消化病医院,西安,710032 2017
Subjects
Online AccessGet full text
ISSN1001-5256
DOI10.3969/j.issn.1001-5256.2017.09.010

Cover

Abstract 炎症反应和免疫功能紊乱在慢加急性肝衰竭的病程进展中发挥关键作用,导致全身炎症反应综合征,过度的炎症及免疫反应,导致感染易感性增加,最终出现多脏器功能衰竭(MODS)。消除肝损伤并纠正免疫紊乱可预防败血症和(或)MODS,改善患者的生存。迄今为止,ACLF的免疫治疗在各大治疗指南中尚未被推荐。然而,作为ACLF重要病理生理改变,并且与发病率、病死率密切相关的关键事件——肝脏局部和全身炎症反应持续激活及免疫细胞功能障碍,又促使我们不得不考虑免疫调节治疗,以阻断和逆转疾病的进展。因此,简述了目前应用于ACLF治疗的具有潜在免疫调节作用的药物,包括传统药物白蛋白、糖皮质激素等使用,粒细胞集落刺激因子、人工肝支持系统及间充质干细胞移植等的应用,并讨论了一些有希望的未来免疫治疗靶点。
AbstractList R575.3; 炎症反应和免疫功能紊乱在慢加急性肝衰竭的病程进展中发挥关键作用,导致全身炎症反应综合征,过度的炎症及免疫反应,导致感染易感性增加,最终出现多脏器功能衰竭(MODS).消除肝损伤并纠正免疫紊乱可预防败血症和(或)MODS,改善患者的生存.迄今为止,ACLF的免疫治疗在各大治疗指南中尚未被推荐.然而,作为ACLF重要病理生理改变,并且与发病率、病死率密切相关的关键事件——肝脏局部和全身炎症反应持续激活及免疫细胞功能障碍,又促使我们不得不考虑免疫调节治疗,以阻断和逆转疾病的进展.因此,简述了目前应用于ACLF治疗的具有潜在免疫调节作用的药物,包括传统药物白蛋白、糖皮质激素等使用,粒细胞集落刺激因子、人工肝支持系统及间充质干细胞移植等的应用,并讨论了一些有希望的未来免疫治疗靶点.
炎症反应和免疫功能紊乱在慢加急性肝衰竭的病程进展中发挥关键作用,导致全身炎症反应综合征,过度的炎症及免疫反应,导致感染易感性增加,最终出现多脏器功能衰竭(MODS)。消除肝损伤并纠正免疫紊乱可预防败血症和(或)MODS,改善患者的生存。迄今为止,ACLF的免疫治疗在各大治疗指南中尚未被推荐。然而,作为ACLF重要病理生理改变,并且与发病率、病死率密切相关的关键事件——肝脏局部和全身炎症反应持续激活及免疫细胞功能障碍,又促使我们不得不考虑免疫调节治疗,以阻断和逆转疾病的进展。因此,简述了目前应用于ACLF治疗的具有潜在免疫调节作用的药物,包括传统药物白蛋白、糖皮质激素等使用,粒细胞集落刺激因子、人工肝支持系统及间充质干细胞移植等的应用,并讨论了一些有希望的未来免疫治疗靶点。
Abstract_FL Inflammatory response and immune dysfunction play important roles in the progression of acute-on-chronic liver failure (ACLF) and may lead to systemic inflammatory response syndrome.Excessive inflammatory and immune response may result in increased susceptibility to infection and finally lead to multiple organ dysfunction syndrome (MODS).Elimination of liver injury and correction of immune dysfunction can prevent sepsis and/or MODS and improve patients' survival.Up to now,immunotherapy for ACLF has not been recommended in related guidelines.However,as an important pathophysiological change of ACLF and a key event closely associated with incidence rate and mortality rate,persistent activation of hepatic and systemic inflammatory response and immune cel1 dysfunction urges us to consider immunoregulatory treatment,in order to block and reverse disease progression.This article introduces potential immunoregulatory drugs for the treatment of ACLF,including albumin,glucocorticoids,granulocyte colony-stimulating factor,artificial liver support system,and mesenchymal stem cell transplantation,and discusses some promising targets for immunotherapy.
Author 韩英 崔丽娜 郭冠亚
AuthorAffiliation 第四军医大学西京消化病医院,西安710032
AuthorAffiliation_xml – name: 第四军医大学西京消化病医院,西安,710032
Author_FL CUI Lina
GUO Guanya
HAN Ying
Author_FL_xml – sequence: 1
  fullname: HAN Ying
– sequence: 2
  fullname: CUI Lina
– sequence: 3
  fullname: GUO Guanya
Author_xml – sequence: 1
  fullname: 韩英 崔丽娜 郭冠亚
BookMark eNo9j81Kw0AUhWdRwVr7EtKFm8Q7M5kZZynFPyi40H24mUxqSp1ogohdFbEbwW0FQVBBXBRB3Po8TfoYRiquDhw-zuFbIw2XOUtIh4LPtdRbAz8tCudTAOoJJqTPgCoftA8UGqT536-SdlGkEQjKpQ6EbJJOOXmd3z2X47dy_L64eVq8fFazj-rxdj65r6az8uu7mj6sk5UEh4Vt_2WLHO_tnnQPvN7R_mF3p-cZCeCZADRLcBsZ57EUKJURVAttKdeRRg4qYFYkmloLGKNChoZqCNAgJirhLbK5XL1Cl6Drh4PsMnf1Xzg0_TgajX6lQNdKNbqxRM1p5voXaQ2f5-kZ5tehVJxJJQPgP2J9XUY
ClassificationCodes R575.3
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3969/j.issn.1001-5256.2017.09.010
DatabaseName 中文期刊服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Immunotherapy for acute-on-chronic liver failure
DocumentTitle_FL Immunotherapy for acute-on-chronic liver failure
EndPage 1682
ExternalDocumentID lcgdbzz201709010
673267640
GroupedDBID -05
2B.
2C~
2RA
5XA
5XF
92F
92I
92L
ABDBF
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CIEJG
CQIGP
CW9
EAD
EAP
EOJEC
ESX
GROUPED_DOAJ
IPNFZ
OBODZ
OK1
RIG
RNS
TCJ
TGQ
U1G
U5O
W91
~WA
4A8
93N
ABJNI
ACUHS
PSX
ID FETCH-LOGICAL-c600-c4092fa8a233d65a67c51959e139b9a30742e5f91ee0ada7a2ac1904acaaf7f3
ISSN 1001-5256
IngestDate Thu May 29 03:59:50 EDT 2025
Wed Feb 14 09:57:01 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords 肝功能衰竭
多器官功能衰竭
免疫疗法
治疗
multiple organ failure
liver failure
therapy
immunotherapy
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c600-c4092fa8a233d65a67c51959e139b9a30742e5f91ee0ada7a2ac1904acaaf7f3
Notes HAN Ying, CUI Lina, GUO Guanya. ( Xijing Hospital of Digestive Disease, Fourth Military Medical University, Xi'an 710032, China)
liver failure; multiple organ failure; immunotherapy; therapy
Inflammatory response and immune dysfunction play important roles in the progression of acute-on-chronic liver failure( ACLF) and may lead to systemic inflammatory response syndrome. Excessive inflammatory and immune response may result in increased susceptibility to infection and finally lead to multiple organ dysfunction syndrome( MODS). Elimination of liver injury and correction of immune dysfunction can prevent sepsis and/or MODS and improve patients'survival. Up to now,immunotherapy for ACLF has not been recommended in related guidelines. However,as an important pathophysiological change of ACLF and a key event closely associated with incidence rate and mortality rate,persistent activation of hepatic and systemic inflammatory response and immune cell dysfunction urges us to consider immunoregulatory treatment,in order
PageCount 6
ParticipantIDs wanfang_journals_lcgdbzz201709010
chongqing_primary_673267640
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationTitle 临床肝胆病杂志
PublicationTitleAlternate Chinese Journal of Clinical Hepatology
PublicationTitle_FL Journal of Clinical Hepatology
PublicationYear 2017
Publisher 第四军医大学西京消化病医院,西安,710032
Publisher_xml – name: 第四军医大学西京消化病医院,西安,710032
SSID ssib051369456
ssj0041983
ssib001103858
ssib053243598
ssib002264326
ssib038074677
Score 2.0629666
Snippet ...
R575.3;...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 1677
SubjectTerms 免疫疗法
多器官功能衰竭
治疗
肝功能衰竭
Title 慢加急性肝衰竭的免疫治疗
URI http://lib.cqvip.com/qk/90100X/201709/673267640.html
https://d.wanfangdata.com.cn/periodical/lcgdbzz201709010
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NaxQxFA_rFooX8RNrVSrsO5Wpk5lMJjkm3V2KUC9W6G3JZGa2B9n6sb3sqUh7EbxWEAQVxEMRxKt_T3f7Z5hkMtupSFFhGbJv895L9s2E34T3fkGoQ7m2wFYFOMVZQHSYB1mZ50FYkEJjUurSHeez-ZhuPCWPtpPtVuugkbW0N87W9OSPdSX_E1UjM3G1VbL_ENm5USMwbRNfczURNte_ijH0KLAERAS9BJgAETpJCCKpGyn0GLAIeNc2BAZp-qQgJIiubXABjDh186kk1P5q1GUEUnpJld1ao1joEZAMpFOUwrpuemExMOoUU2vWmDJy5gYp-7UpE2ToceB9ENwpSZB41fUhwEntomslggFfX7XdjWnhRMaBnS2x7rlo7l1URZp-obWpXElUkYrXK3FFieHvON5YVjH1Z70U_mt1YNHvy3_MKXfLv3WxNndhE_hSx2brM2jPE2zT1EDYlJLwElqI0hQnbbQgZFf2z2AlDs9x_tji4wbstZz9pEELmOCYcnLGUZQY0GqJEmuEQDBnVeGHH-Ai6vjRP7xo7Jb-Y2d3NHxhQI2rMRuVajRswKGtq-iKf49ZEdVNeQ21JjvX0eKmz9S4gTrTw88nbz5O979M97-evv5w-un77Pjb7P3ByeHb2dHx9MfP2dG7m-hJv7e1vhH4EzkCbYBxoEnIo1IxFcVxThNFU-3IiQrzGpFxFdt9liIpOS6KUOUqVZHSBnASpZUq0zK-hdqj3VFxG60Y1JoVPIsJZ5ioXGeqiHJKi1IzwjKKl9DyfKqD5xXvymAeqCX0wE9-4J_GV4Nnephnk4n9u0KbcnTnQgvL6LLtWe2l3UXt8cu94p5Bl-Psvg_-L7R4V1o
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%85%A2%E5%8A%A0%E6%80%A5%E6%80%A7%E8%82%9D%E8%A1%B0%E7%AB%AD%E7%9A%84%E5%85%8D%E7%96%AB%E6%B2%BB%E7%96%97&rft.jtitle=%E4%B8%B4%E5%BA%8A%E8%82%9D%E8%83%86%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E9%9F%A9%E8%8B%B1+%E5%B4%94%E4%B8%BD%E5%A8%9C+%E9%83%AD%E5%86%A0%E4%BA%9A&rft.date=2017&rft.issn=1001-5256&rft.volume=33&rft.issue=9&rft.spage=1677&rft.epage=1682&rft_id=info:doi/10.3969%2Fj.issn.1001-5256.2017.09.010&rft.externalDocID=673267640
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F90100X%2F90100X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcgdbzz%2Flcgdbzz.jpg